Literature DB >> 16881345

How to avoid glucose degradation products in peritoneal dialysis fluids.

Martin Erixon1, Anders Wieslander, Torbjörn Lindén, Ola Carlsson, Gunita Forsbäck, Eva Svensson, Jan Ake Jönsson, Per Kjellstrand.   

Abstract

OBJECTIVE: The formation of glucose degradation products (GDPs) during sterilization of peritoneal dialysis fluids (PDFs) is one of the most important aspects of biocompatibility of glucose-containing PDFs. Producers of PDFs are thus trying to minimize the level of GDPs in their products. 3,4-Dideoxyglucosone-3-ene (3,4-DGE) has been identified as the most bioreactive GDP in PDFs. It exists in a temperature-dependent equilibrium with a pool of 3-deoxyglucosone (3-DG) and is a precursor in the irreversible formation of 5-hydroxymethyl furaldehyde (5-HMF). The aim of the present study was to investigate how to minimize GDPs in PDFs and how different manufacturers have succeeded in doing so.
DESIGN: Glucose solutions at different pHs and concentrations were heat sterilized and 3-DG, 3,4-DGE, 5-HMF, formaldehyde, and acetaldehyde were analyzed. Conventional as well as biocompatible fluids from different manufacturers were analyzed in parallel for GDP concentrations.
RESULTS: The concentrations of 3-DG and 3,4-DGE produced during heat sterilization decreased when pH was reduced to about 2. Concentration of 5-HMF decreased when pH was reduced to 2.6. After further decrease to a pH of 2.0, concentration of 5-HMF increased slightly, and below a pH of 2.0 it increased considerably, together with formaldehyde; 3-DG continued to drop and 3,4-DGE remained constant. Inhibition of cell growth was paralleled by 3,4-DGE concentration at pH 2.0 - 6.0. A high glucose concentration lowered concentrations of 3,4-DGE and 3-DG at pH 5.5 and of 5-HMF at pH 1. At pH 2.2 and 3.2, glucose concentration had a minor effect on the formation of GDPs. All conventional PDFs contained high levels of 3,4-DGE and 3-DG. Concentrations were considerably lower in the biocompatible fluids. However, the concentration of 5-H M F was slightly higher in all the biocompatible fluids.
CONCLUSION: The best way to avoid reactive GDPs is to have a pH between 2.0 and 2.6 during sterilization. If pHs outside this range are used, it becomes more important to have high glucose concentration during the sterilization process. There are large variations in GDPs, both within and between biocompatible and conventionally manufactured PDFs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16881345

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  18 in total

Review 1.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 2.  Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.

Authors:  Seychelle Yohanna; Ali M A Alkatheeri; Scott K Brimble; Brendan McCormick; Arthur Iansavitchous; Peter G Blake; Arsh K Jain
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

3.  Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells.

Authors:  Yihui Zhai; Jacek Bloch; Meike Hömme; Julia Schaefer; Thilo Hackert; Bärbel Philippin; Vedat Schwenger; Franz Schaefer; Claus P Schmitt
Journal:  Pediatr Nephrol       Date:  2012-03-01       Impact factor: 3.714

4.  A new neutral-pH low-GDP peritoneal dialysis fluid.

Authors:  Rainer Himmele; Lynn Jensen; Dominik Fenn; Chih-Hu Ho; Dixie-Ann Sawin; Jose A Diaz-Buxo
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

5.  Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group.

Authors:  Claus Peter Schmitt; Sevcan A Bakkaloglu; Günter Klaus; Cornelis Schröder; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2011-03-31       Impact factor: 3.714

6.  Neuronal damage and shortening of lifespan in C. elegans by peritoneal dialysis fluid: Protection by glyoxalase-1.

Authors:  Andrea Schlotterer; Friederike Pfisterer; Georgi Kukudov; Britta Heckmann; Daniel Henriquez; Christian Morath; Bernhard K Krämer; Hans-Peter Hammes; Vedat Schwenger; Michael Morcos
Journal:  Biomed Rep       Date:  2018-04-03

7.  Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

Authors:  J Haybrard; N Simon; C Danel; C Pinçon; C Barthélémy; F J Tessier; B Décaudin; E Boulanger; P Odou
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

8.  Infusion fluids contain harmful glucose degradation products.

Authors:  Anna Bryland; Marcus Broman; Martin Erixon; Bengt Klarin; Torbjörn Lindén; Hans Friberg; Anders Wieslander; Per Kjellstrand; Claudio Ronco; Ola Carlsson; Gabriela Godaly
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

Review 9.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

10.  Interference of peritoneal dialysis fluids with cell cycle mechanisms.

Authors:  Janine Büchel; Maria Bartosova; Gwendolyn Eich; Timo Wittenberger; Ludger Klein-Hitpass; Sonja Steppan; Thilo Hackert; Franz Schaefer; Jutta Passlick-Deetjen; Claus P Schmitt
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.